Calcineurin

From WikiMD's WELLNESSPEDIA


File:Protein PPP3CA PDB 1aui.png
Structure of Calcineurin (PPP3CA)

Calcineurin is a calcium and calmodulin-dependent serine/threonine protein phosphatase involved in a variety of cellular processes. It is a key player in the immune system, particularly in the activation of T-cells. Calcineurin is also important in the nervous system, where it regulates neuronal activity and synaptic plasticity.

Structure[edit]

Calcineurin is a heterodimeric protein composed of two subunits: the catalytic subunit A (PPP3CA) and the regulatory subunit B. The catalytic subunit contains the active site and is responsible for the phosphatase activity, while the regulatory subunit binds calcium ions and calmodulin, which are essential for the activation of calcineurin.

Function[edit]

Calcineurin plays a crucial role in the signal transduction pathways of T-cells. Upon activation by calcium and calmodulin, calcineurin dephosphorylates the nuclear factor of activated T-cells (NFAT), allowing it to translocate into the nucleus and activate the transcription of genes necessary for T-cell activation and proliferation.

In the nervous system, calcineurin is involved in the regulation of neurotransmitter release and long-term potentiation, which are critical for learning and memory.

Clinical Significance[edit]

Calcineurin inhibitors, such as cyclosporine and tacrolimus, are widely used as immunosuppressants in organ transplantation to prevent rejection. These drugs inhibit calcineurin activity, thereby suppressing T-cell activation and the immune response.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.